Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Small Cell Lung Carcinoma 3Rectal Neoplasms 3Colorectal Neoplasms 3Polycystic Ovary Syndrome 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sprains and Strains 1Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Insulin Resistance 1Febrile Neutropenia 1Breast Neoplasms 1

Interventions

Oxaliplatin 47Capecitabine 46Fluorouracil 40Leucovorin 30Radiotherapy 25Irinotecan 20Chemoradiotherapy 14Bevacizumab 14Cetuximab 12Neoadjuvant Therapy 11Folfox protocol 11Chemotherapy, Adjuvant 11Laparoscopy 10XELOX 9Drug Therapy 9Surgical Procedures, Operative 6Robotic Surgical Procedures 5Radiation 5Mastectomy, Segmental 5Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Panitumumab 4Gemcitabine 4durvalumab 3Simvastatin 3Magnetic Resonance Spectroscopy 3Indocyanine Green 3FOLFOXIRI protocol 3tislelizumab 2regorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Rectal Neoplasms × Simvastatin × Clear all
NCT02161822 2020-03-25

Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

Samsung Medical Center

Phase 2 Unknown
60 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01110785 2013-09-17

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01190462 2013-08-12

Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
51 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡